14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $11.17 0 %
High/ Low $11.17 - $11.17 0%
Chg 7 Days N/A $11.17 $11.17
Chg 30 Days N/A $11.17 $11.17
Chg 12 mos -7.07 % $12.02 $11.17
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 87.83 % Width: 79.74 %
Pred. range - 3 mos $11.17 - $11.17 0 % - 0 %
Pred. range - 12 mos $16.10 - $28.94 44.15 % - 159.10 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Dec 21, 2022 - 67 days
Long MA avg 12 mos Buy Aug 02, 2022 - 166 days
Short/Long MA avg 12 mos Buy Aug 05, 2022 - 163 days
Pivot Short Sell Mar 28, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Oyster Point Pharma Inc

Oyster Point Pharma Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for ... OYST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT